Targeting expression of a transgene to the airway surface epithelium using a ciliated cell-specific promoter
Open Access
- 31 October 2003
- journal article
- Published by Elsevier BV in Molecular Therapy
- Vol. 8 (4), 637-645
- https://doi.org/10.1016/s1525-0016(03)00221-1
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- An overview of the pathogenesis of cystic fibrosis lung diseaseAdvanced Drug Delivery Reviews, 2002
- Enhanced Epithelial Gene Transfer by Modulation of Tight Junctions with Sodium CaprateAmerican Journal of Respiratory Cell and Molecular Biology, 2000
- Adeno-Associated Virus Type 5 (AAV5) but Not AAV2 Binds to the Apical Surfaces of Airway Epithelia and Facilitates Gene TransferJournal of Virology, 2000
- Increasing Epithelial Junction Permeability Enhances Gene Transfer to Airway Epithelia In VivoAmerican Journal of Respiratory Cell and Molecular Biology, 2000
- Status of gene therapy for cystic fibrosis lung diseaseJCI Insight, 1999
- EnhancedIn VivoAirway Gene Transfer via Transient Modification of Host Barrier Properties with a Surface-Active AgentHuman Gene Therapy, 1998
- Cystic fibrosis.American Journal of Respiratory and Critical Care Medicine, 1996
- Gene therapy for cystic fibrosis: challenges and future directions.JCI Insight, 1995
- Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cellsNature, 1990
- Correction of the cystic fibrosis defect in vitro by retrovirus-mediated gene transferCell, 1990